US 10294296
Treatment for neoplastic diseases
granted A61KA61K2039/505A61P
Quick answer
US patent 10294296 (Treatment for neoplastic diseases) held by XBIOTECH INC. expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XBIOTECH INC.
- Grant date
- Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P11/00